Platelet phenomics analysis to be performed at admission, at approximately 2 months (when likely to be on dual anti-plat clinical trials

Using platelet function analysis to personalise anti-thrombotic drug therapies

This study looks at a new blood test for people who have had a certain type of heart attack. It aims to find out if this test can help doctors choose the best anti-clotting medicines, to prevent future problems while reducing risks like bleeding. It runs until 2030.